Overview
Tropical splenomegaly syndrome (TSS) is characterized by splenomegaly and often associated with macroglobulinemia, primarily elevated IgM levels, likely due to dysregulation in immune function, particularly involving suppressor T lymphocytes. 12Diagnosis
Elevated serum IgM levels, often with a wide range (150–3000 mg/100 ml). 2
Presence of splenomegaly.
Functional assessment showing decreased activity or number of suppressor T cells (T8+ phenotype). 1
Specific IgM antibodies targeting T8+ T cells noted in some patients. 1Management
No specific first-line treatments mentioned in the abstracts.
Monitoring and managing complications related to splenomegaly and hyperviscosity syndrome (if applicable).
Addressing underlying parasitic infections, particularly malaria, though direct evidence for treatment efficacy is not provided. 2Special Populations
No specific data provided for pregnancy, pediatrics, elderly, or comorbidities in the given abstracts. 12Key Recommendations
Evaluate serum IgM levels in patients suspected of TSS to confirm macroglobulinemia. (Evidence: Moderate) 2
Consider functional immune assays to assess T cell subsets, particularly suppressor T cells, for deeper understanding of immune dysregulation. (Evidence: Weak) 1
Manage underlying parasitic infections, particularly malaria, as part of comprehensive care, though direct evidence linking specific treatments to TSS outcomes is lacking. (Evidence: Expert opinion) 2References
1 Piessens WF, Hoffman SL, Wadee AA, Piessens PW, Ratiwayanto S, Kurniawan L et al.. Antibody-mediated killing of suppressor T lymphocytes as a possible cause of macroglobulinemia in the tropical splenomegaly syndrome. The Journal of clinical investigation 1985. link
2 Wells JV. Serum immunoglobulin levels in tropical splenomegaly syndrome in New Guinea. Clinical and experimental immunology 1968. link